openPR Logo
Press release

Biomarkers Market 2018 – Global Industry Trends and Research Forecast to 2024

Biomarkers

Biomarkers

Global Biomarker Market is expected to reach USD 85,927.95 million by 2024 from USD 28,091.78 million in 2016, at a CAGR of 15.1%. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Visit: http://databridgemarketresearch.com/reports/global-biomarkers-market

The factors such as increased usage of biomarkers in cancer treatment, growing efforts towards drug discovery, wide application of biomarkers in personalized medicine and diagnostics, initiatives taken towards biomarker research are furthermore boosting the growth of the global biomarkers market. On the other hand, high capital investment may hinder the growth of the market. The biomarker market in the Global region is leading in North America.

Get Free Sample Research Report: http://databridgemarketresearch.com/request-a-sample/?dbmr=global-biomarkers-market

Market Segmentation: Global Biomarkers Market

• The global biomarker market is segmented on the basis of product type, technology, application and indication. The global biomarkers market is segmented based on product type into three notable segments; consumables, services and software. In 2017, consumables segment is expected to dominate the global biomarkers market with 58.6% market share and is expected to reach USD 51,156.05 million by 2024, with the highest CAGR of 15.4% in the forecast period 2017 to 2024.

• On the basis of technology, global biomarker market is segmented into three notable segments; safety biomarkers, efficacy biomarkers and validation biomarkers. In 2017, safety biomarkers is expected to dominate the global biomarkers market with 47.8% market share and is expected to reach USD 41,933.30 million by 2024, with the highest CAGR of 15.4% in the forecast period 2017 to 2024.

• On the basis of application, global biomarker market is segmented into diagnostics development, drug discovery and development, personalized medicine, disease-risk assessment, and others. In 2017, diagnostic development is expected to dominate the market with the market share of 35.4% the market is expected to reach USD 29,148.7 million by 2024, growing at a CAGR of 14.4% in the forecast period 2017 to 2024. However, personalized medicine is expected to grow at the highest CAGR of 16.2% in the forecast period, and is expected to reach USD 19,520.5 million in 2024 from USD 5,901.5 million in 2016.

• The Global biomarkers market is segmented based on indication into four notable segments; cancer, cardiovascular disorders, neurological disorders, immunological disorders, and others diseases. In 2017, cancer is expected to dominate the global biomarkers market with 38.0% market share and is expected to reach USD 32,632.11 million by 2024, with a CAGR of 15.1% in the forecast period 2017 to 2024. However, cardiovascular disorders is expected to grow at the highest CAGR of 15.9% in the forecast period, and is expected to reach USD 25,063.53 million in 2024 from USD 7,736.13 million in 2016

BIO-RAD LABORATORIES INC.:

Founded in 1952 and headquartered in California, U.S. Bio-Rad laboratories, Inc. develops and commercializes the wide range of products and systems in the healthcare, life science research, analytical chemistry and few other areas, which is used for the separation of composite chemical and biological ingredients and for the analysis and purification of their components. Bio-Rad operates its business in two industry segments named as life science and clinical diagnostics. Clinical Diagnostics segment manufactures, commercializes informatics systems, test systems, test kits and quality controls for the clinical laboratories.

Bio-rad has its presence across the globe in United States, Australia, Greece, Portugal, Austria, Hong Kong, Russia, Belgium, France, Hungary, South Africa, Singapore, Brazil, India, Canada, Israel, South Korea, China, Italy, Spain, Czech Republic, Japan, Sweden, Denmark, Netherlands, Mexico, Switzerland, Egypt, Taiwan, Finland, New Zealand, Thailand, Norway, United Kingdom, Germany, and Poland.

PERKINELMER INC.:

Incorporated in 1947 and headquartered in Massachusetts, U.S. PerkinElmer, Inc. is a supplier and manufacturer of products, services and solutions for the food, diagnostics, industrial, environmental, life sciences research and laboratory services markets. The company operates its business through two business segments which includes discovery & analytical solutions and diagnostics. The diagnostics segment provides products and wide range of reagents, instruments, assay platforms, and software for hospitals, medical labs, clinicians, and medical research professionals. The segment focusses on the areas such as reproductive health, developing market diagnostics, and applied genomics.

PerkinElmer develops, manufactures and markets a broad range of branded, generic and branded generic pharmaceutical products which are marketed directly or indirectly in U.S. and across the globe. The company commercializes products and services in over 150 countries.

QIAGEN:-

Founded in 1984 and headquartered at Hilden, Germany, Qiagen is engaged in sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. The company operates through different business segments, namely Next-Gen Sequencing, Molecular Diagnostic, Life Sconce Research, Animal and Vet. Testing, Bioinformatics and others. The molecular diagnostic segment includes Oncology, Infectious Disease, Tuberculosis Management, Transplantation Testing and Women’s health. Next-Gen Sequencing covers GeneReader NGS System and QIAseq NGS Solutions.

Qiagen has its operations across the North America, Europe, Middle East and Africa, Asia-Pacific and rest of world. Some of its subsidiaries include Exiqon (Denmark), Cellestis (Australia), Tiangen Biotech Co. Ltd. (Beijing), Qiagen Ltd. (India), Ipsogen SA (France) and many more subsidiaries across the globe.

Speak to Research Analyst: http://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-biomarkers-market

Key Drivers: Global Biomarkers Market
Global biomarker market is growing with the increased usage of biomarkers in cancer treatment, growing efforts towards drug discovery, wide application of biomarkers in personalized medicine and diagnostics, initiatives taken towards biomarker research are furthermore boosting the growth of the global biomarkers market.

Table Of Contents

1. Introduction
1.1. Objectives Of The Study
1.2. Market Definition
1.3. Overview Of Global Biomarkers Market
1.4. Currency And Pricing
1.5. Limitation
1.6. Markets Covered
2. Market Segmentation
2.1. Markets Covered
2.2. Geographic Scope
2.3. Years Considered For The Study
2.4. Currency And Pricing
2.5. Research Methodology
2.6. Primary Interviews With Key Opinion Leaders
2.7. Secondary Sources
2.8. Assumptions
3. Market Overview
3.1. Drivers
3.1.1. Increased Usage Of Biomarkers In Cancer Treatment
3.1.2. Growing Efforts Towards Drug Discovery
3.1.3. Wide Application Of Biomarkers In Personalized Medicine And Diagnostics
3.1.4. Initiatives Taken Towards Biomarker Research
3.2. Restraints
3.2.1. Unfavourable Reimbursement Systems
3.2.2. High Capital Investments
3.2.3. High Costing Involved In Sample Collection And Storage
3.3. Opportunities
3.3.1. Emerging Economies
3.4. Challenges
3.4.1. Demonstrating The Clinical Validity In Biomarker-Based Tests
4. Executive Summary
5. Premium Insights

Continue…

Want Full Report? Inquire For Buy: http://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-biomarkers-market

About Us
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us
Vishal Dixit
Data Bridge Market Research
Toll Free: +1-888-387-2818
Mail: sales@databridgemarketresearch.com
http://databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Biomarkers Market 2018 – Global Industry Trends and Research Forecast to 2024 here

News-ID: 957988 • Views:

More Releases from Data Bridge Market Research

Unveiling the Power: Radio Frequency Identification (RFID) Middleware in Modern Operations
Unveiling the Power: Radio Frequency Identification (RFID) Middleware in Modern …
Data Bridge Market Research analyses that the radio frequency identification (RFID) middleware market will exhibit a CAGR of 10.15% for the forecast period of 2022-2022 and is expected to reach the market value of USD 5.03 billion by 2029. Radio Frequency Identification (RFID) refers to a wireless system comprised of two components tags and readers. The reader is a device that has one or more antennas that emit radio waves and
Streamlining Service: Innovations in Hospitality Management Software
Streamlining Service: Innovations in Hospitality Management Software
The hospitality management software market is expected to witness market growth at a rate of 8.37% in the forecast period of 2022 to 2029. Data Bridge Market Research report on hospitality management software market provides analysis and insights regarding the various factors expected to be prevalent throughout the forecast period while providing their impacts on the market's growth. The rise in the adoption of the cloud-based hotel management software is
SCARA Robot Market to Observe Highest Growth of USD 28,345.20 billion with an Excellent CAGR of 27.10% by 2028
SCARA Robot Market to Observe Highest Growth of USD 28,345.20 billion with an Ex …
Global Scara Robot Market study by Data Bridge Market Research provides details about the market dynamics affecting the Scara Robot market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years. A number of estimations and calculations have been included in the first class Scara Robot market report by assuming definite base year and the historic year. The
Ammonium Sulfate Market to Observe Prominent CAGR of 3.85% by 2028, Size, Share, Trends, Demand, Growth, Challenges and Competitive Outlook
Ammonium Sulfate Market to Observe Prominent CAGR of 3.85% by 2028, Size, Share, …
Data Bridge Market research has recently issued comprehensive industry research on Global Ammonium Sulfate Market which includes growth analysis, regional marketing, challenges, opportunities, and drivers analysed in the report. The market insights gained through this Ammonium Sulfate market research analysis report facilitates more defined understanding of the market landscape, issues that may interrupt in the future, and ways to position definite brand excellently. An analysis of competitors is conducted very well

All 5 Releases


More Releases for Biomarker

Brain Biomarker Market 2021 | Detailed Report
The Brain Biomarker research report combines vital data incorporating the competitive landscape, global, regional, and country-specific market size, market growth analysis, market share, recent developments, and market growth in segmentation. Furthermore, the Brain Biomarker research report offers information and thoughtful facts like share, revenue, historical data, and global market share. It also highlights vital aspects like opportunities, driving, product scope, market overview, and driving force. Get Free Sample PDF (including full
Global Biomarker Market 2021 : Clinical Diagnostic, Drug Discovery, Diagnostic B …
This "Biomarker Market" to portray important bits of knowledge identified with critical market patterns driving the business. The Biomarker report incorporates a scope of inhibitors just as main impetuses of the market which are broke down in both subjective and quantitative methodology so perusers and clients get exact data and experiences about industry. Factual information referenced in the report is represented with the assistance of diagrams which improves on the
Impact of Outbreak of Coronavirus (Covid-19) on Biomarker Technologies Market 20 …
The Biomarker Technologies market is expected to reach USD 92 Billion by 2027 from USD 60 Billion in 2019, at a CAGR of 10% during the forecast period. A comprehensive report on Biomarker Technologies Market was published by Research N Reports to understand the complete setup of Biomarker Technologies Market industries. Effective qualitative and quantitative analysis techniques have been used to examine the data accurately. Variable factors that comprise basis
Biomarker Technologies Market – Major Technology Giants in Buzz Again | Biomar …
A New Research on the Global Biomarker Technologies Market was conducted across a variety of industries in various regions to produce more than 150 page reports. This study is a perfect blend of qualitative and quantifiable information highlighting key market developments, industry and competitors' challenges in gap analysis and new opportunities and may be trending in the Biomarker Technologies market. Some are part of the coverage and are the core
Global Cancer Biomarker Market Advantages & Developments 2025
Qyresearchreports include new market research report "Global Cancer Biomarker Market Size,Status and Forecast 2025" to its huge collection of research reports. The global Cancer Biomarker market has been exclusively and elaborately examined in this report while taking into account some of the most pivotal factors holding the capability to influence growth. For the said forecast tenure, the report has shed light on critical market dynamics, which include trends, opportunities, restraints, and
Biomarker Technologies Market : Analysis & Trends 2025
A biomarker also known as biological marker is a gene, molecule or characteristic by which biological state of the body is measured in order to assess and predict a particular disease or some other physiological state of an individual. It helps clinicians in disease identification and effectively plan treatment process. Biomarkers are extensively applied for diagnosis and clinical decision making in various medical specialties including cancer, diabetes, cardiovascular and neurological